These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28509794)

  • 1. An Allometric Model of Remifentanil Pharmacokinetics and Pharmacodynamics.
    Eleveld DJ; Proost JH; Vereecke H; Absalom AR; Olofsen E; Vuyk J; Struys MMRF
    Anesthesiology; 2017 Jun; 126(6):1005-1018. PubMed ID: 28509794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.
    Minto CF; Schnider TW; Egan TD; Youngs E; Lemmens HJ; Gambus PL; Billard V; Hoke JF; Moore KH; Hermann DJ; Muir KT; Mandema JW; Shafer SL
    Anesthesiology; 1997 Jan; 86(1):10-23. PubMed ID: 9009935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
    Eleveld DJ; Colin P; Absalom AR; Struys MMRF
    Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Population pharmacokinetic modeling and evaluation of propofol from multiple centers].
    Ye HB; Zheng H; Zhang XA; Chi XJ; Chen WY; Xu JG; Li JH; Rui JZ
    Yao Xue Xue Bao; 2010 Dec; 45(12):1550-8. PubMed ID: 21351496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.
    Minto CF; Schnider TW; Shafer SL
    Anesthesiology; 1997 Jan; 86(1):24-33. PubMed ID: 9009936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general purpose pharmacokinetic model for propofol.
    Eleveld DJ; Proost JH; Cortínez LI; Absalom AR; Struys MM
    Anesth Analg; 2014 Jun; 118(6):1221-37. PubMed ID: 24722258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty.
    Standing JF; Hammer GB; Sam WJ; Drover DR
    Paediatr Anaesth; 2010 Jan; 20(1):7-18. PubMed ID: 19825011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil.
    Cascone S; Lamberti G; Piazza O; Abbiati RA; Manca D
    Eur J Pharm Sci; 2018 Jan; 111():20-28. PubMed ID: 28939143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.
    Ross AK; Davis PJ; Dear Gd GL; Ginsberg B; McGowan FX; Stiller RD; Henson LG; Huffman C; Muir KT
    Anesth Analg; 2001 Dec; 93(6):1393-401, table of contents. PubMed ID: 11726413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models.
    Masui K; Ishigaki S; Tomita A; Otake H
    J Anesth; 2018 Oct; 32(5):709-716. PubMed ID: 30099599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population pharmacokinetic model of remifentanil in pediatric patients using body-weight-dependent allometric exponents.
    Staschen CM; Mahmood I
    Drug Metabol Drug Interact; 2013; 28(4):231-7. PubMed ID: 24114900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteers.
    Egan TD; Kern SE; Muir KT; White J
    Br J Anaesth; 2004 Mar; 92(3):335-43. PubMed ID: 14970134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Optimized Pharmacokinetic Model of Dexmedetomidine Using Target-controlled Infusion in Healthy Volunteers.
    Hannivoort LN; Eleveld DJ; Proost JH; Reyntjens KM; Absalom AR; Vereecke HE; Struys MM
    Anesthesiology; 2015 Aug; 123(2):357-67. PubMed ID: 26068206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of Remifentanil in Obesity: A New Pharmacokinetic Model Incorporating the Influence of Body Mass.
    Kim TK; Obara S; Egan TD; Minto CF; La Colla L; Drover DR; Vuyk J; Mertens M;
    Anesthesiology; 2017 Jun; 126(6):1019-1032. PubMed ID: 28509796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia.
    Park JH; Choi SM; Park JH; Lee KH; Yun HJ; Lee EK; Choi BM; Noh GJ
    Br J Anaesth; 2018 Sep; 121(3):559-566. PubMed ID: 30115253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
    Cortínez LI; Anderson BJ; Penna A; Olivares L; Muñoz HR; Holford NH; Struys MM; Sepulveda P
    Br J Anaesth; 2010 Oct; 105(4):448-56. PubMed ID: 20710020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
    Bienert A; Wiczling P; Zaba C; Zaba Z; Wolc A; Marciniak R; Grześkowiak E; Kusza K
    Arzneimittelforschung; 2011; 61(10):545-52. PubMed ID: 22164962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
    Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
    Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.